University of Utah Center for Alzheimer's Care, Imaging and Research
Welcome,         Profile    Billing    Logout  
 5 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hoffman, John M
NCT02317783: Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Active, not recruiting
2
10
US
[18F]Flutemetamol, [18F]GE067, Vizamyl, [18F]Flutemetamol-PET/CT, [18F]fluoro-2-deoxy-D-glucose (FDG), FDG, [18F]FDG, FDG-PET/CT, Functional Magnetic Resonance Imaging (fMRI), MRI, fMRI
University of Utah
Breast Cancer
01/25
01/26
NCT03276676: [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

Terminated
1/2
10
US
[18F]FLT, [18F]Fluciclovine
University of Utah, Blue Earth Diagnostics
Brain Tumor
04/21
08/23
NCT01246869: Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Terminated
1
2
US
[18F]fluoro-2-deoxy-D-glucose (FDG), FDG, [18F]FDG, FDG-PET/CT, 1H-1-(3-[18F]-fluoro-2-hydroxy-propyl)-2-nitro-imidazole [18F]-fluoromisonidazole, [18F]FMISO, FMISO, FMISO-PET/CT, [15O]water, H2[15O], H2[15O]-PET-CT, Magnetic Resonance Imaging, MRI
University of Utah
Brain Cancer
05/14
05/14
Duff, Kevin
APPE, NCT03466736: Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects

Completed
N/A
165
US
[18F]flutemetamol PET scan
University of Utah, National Institutes of Health (NIH)
Alzheimer Disease, Mild Cognitive Impairment
04/23
04/23

Download Options